VOM® V (Volume) with Lidocaine (2 x 1.0 mL) | CGBio
Short Description
A high-density, multi-layered structural Hyaluronic Acid dermal filler formulated with 20 mg/mL of cross-linked HA, 0.3% lidocaine, and CGBio’s proprietary R-Square Technology. Specifically engineered for deep subcutaneous and supraperiosteal placement, VOM® V (Volume) delivers high lifting capacity ($G’$), stable bone-mimetic projection, and sharp contour definition for cheek augmentation, chin sculpting, and jawline definition lasting up to 12 to 18 months.
Detailed Description
VOM® V (Volume) with Lidocaine is an advanced, sterile, physiological cross-linked sodium hyaluronate injectable manufactured by CGBio (South Korea). Designed as the premier structural volumizer in the VOM collection, it restores pronounced age-related facial volume deficits and reinforces skeletal contours.
Engineered with CGBio’s proprietary R-Square Technology, VOM V utilizes a multi-layered matrix that encapsulates a high-viscoelasticity biphasic core within a smooth monophasic outer shell. This hybrid architecture delivers dual performance benefits: the cohesive outer layer facilitates smooth, uniform extrusion forces and natural subcutaneous blending, while the densely cross-linked core provides the structural resilience needed to resist muscular compression (such as the masseter and mentalis muscles) without flattening or migrating laterally. Thoroughly purified through multiple washing cycles, residual BDDE is reduced to non-detectable levels, minimizing post-injection tissue reactivity and swelling.
Treatment Areas & Indications
-
Midface Volumization & Malar Contouring:
-
Malar and cheekbone augmentation (Zygomatic arch projection)
-
Restoration of severe midface volume loss and submalar hollows
-
Deep tissue fat pad deflation support
-
-
Lower Face Sculpting & Profile Harmonization:
-
Chin augmentation, anterior projection, and vertical lengthening
-
Mandibular angle definition and sharp linear jawline contouring
-
Deep pre-jowl sulcus effacement
-
-
Deep Facial Folds & Depressions:
-
Severe, deep nasolabial folds requiring deep structural foundation support
-
Deep labiomental groove (mental crease between lower lip and chin)
-
-
Temporal & Structural Reconstruction:
-
Deep temporal fossa restoration (temple lifting)
-
Key Clinical Advantages
-
Patented R-Square Hybrid Rheology: Combines the projection capacity of a biphasic core with the tissue integration of a monophasic gel, delivering defined structural projection without palpable edges or stiffness.
-
Superior Resistance to Lateral Migration: High cohesive strength keeps deep supraperiosteal boluses securely anchored at the target injection plane, preventing product spreading into adjacent facial compartments.
-
Minimal Post-Procedure Edema: Multi-step dialysis removes unreacted BDDE cross-linkers and endotoxins, substantially reducing immediate inflammatory swelling and post-treatment downtime.
-
Integrated 0.3% Lidocaine: Infused with lidocaine hydrochloride to desensitize deep anatomical planes during high-resistance extrusion, ensuring patient comfort throughout deep bolus delivery.
-
Smooth Injection Mechanics: Optimized viscoelastic flow minimizes hand strain during cannula or needle deposition in dense supraperiosteal and deep subcutaneous planes.
-
Extended In Vivo Longevity: Highly cross-linked molecular core resists enzymatic degradation by endogenous hyaluronidase, sustaining structural volume for 12 to 18 months.
Technical Specifications
| Parameter | Specification |
| Active Substance | Cross-linked Sodium Hyaluronate + 0.3% Lidocaine Hydrochloride |
| HA Concentration | 20 mg/mL (Maximum structural density in the VOM range) |
| Lidocaine Concentration | 3 mg/mL (0.3% w/v) |
| Cross-Linking Technology | R-Square Technology (Multi-layer biphasic core with monophasic outer shell) |
| Packaging Presentation | 2 x 1.0 mL pre-filled sterile glass syringes (Total 2.0 mL) |
| Included Needles | 2 x 25G 1/2” (13 mm) or 27G 1/2” ultra-thin wall disposable needles |
| Target Injection Plane | Deep subcutaneous layer or supraperiosteal (pre-periosteal) plane |
| Recommended Injection Tools | 25G / 27G needle or 22G / 25G blunt-tip microcannula |
| Expected Clinical Duration | 12 to 18 months (dependent on anatomical site, depth, and patient tissue metabolism) |
| Storage Instructions | Store between 2°C to 25°C (36°F to 77°F); protect from direct sunlight and freezing |
| Manufacturer | CGBio Co., Ltd. |
| (South Korea) | Regulatory Category | Medical Device / CE-marked / Prescription Only (Rx) |
Professional Advisory: VOM® V (Volume) with Lidocaine is a high-density medical injectable intended strictly for certified dermatologists, plastic surgeons, and credentialed aesthetic physicians trained in deep facial anatomy, supraperiosteal placement, and vascular safety. Not intended for superficial dermal application or non-clinical consumer use.






Reviews
There are no reviews yet.